FAKTOR OPTIONSSCHEIN - MEDPACE HOLDINGS Share Price

Certificat

DE000GG3VXG4

Real-time BOERSE MUENCHEN 13:25:14 30/05/2024 BST
1.9 EUR 0.00% Intraday chart for FAKTOR OPTIONSSCHEIN - MEDPACE HOLDINGS
Current month-25.20%
1 month-12.44%
Date Price Change
30/05/24 1.9 0.00%
29/05/24 1.9 +25.83%
28/05/24 1.51 -3.82%
27/05/24 1.57 +7.53%
24/05/24 1.46 -5.19%

Real-time BOERSE MUENCHEN

Last update May 30, 2024 at 01:25 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDPACE HOLDINGS, INC.
Issuer Goldman Sachs
WKN GG3VXG
ISINDE000GG3VXG4
Date issued 15/02/2024
Strike 426.8 $
Maturity Unlimited
Parity 21.92 : 1
Emission price 8.61
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.14
Lowest since issue 1.19
Spread 0.1
Spread %5.24%

Company Profile

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Sector
-
More about the company

Ratings for Medpace Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Medpace Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
388 USD
Average target price
428.2 USD
Spread / Average Target
+10.38%
Consensus